Literature DB >> 26618042

Limb Ischemic Perconditioning Attenuates Blood-Brain Barrier Disruption by Inhibiting Activity of MMP-9 and Occludin Degradation after Focal Cerebral Ischemia.

Changhong Ren1, Ning Li2, Brian Wang3, Yong Yang4, Jinhuan Gao5, Sijie Li2, Yuchuan Ding6, Kunlin Jin7, Xunming Ji8.   

Abstract

Remote ischemic perconditioning (PerC) has been proved to have neuroprotective effects on cerebral ischemia, however, the effect of PerC on the BBB disruption and underlying mechanisms remains largely unknown. To address these issues, total 90 adult male Sprague Dawley (SD) rats were used. The rats underwent 90-min middle cerebral artery occlusion (MCAO), and the limb remote ischemic PerC was immediately applied after the onset of MCAO. We found that limb remote PerC protected BBB breakdown and brain edema, in parallel with reduced infarct volume and improved neurological deficits, after MCAO. Immunofluorescence studies revealed that MCAO resulted in disrupted continuity of claudin-5 staining in the cerebral endothelial cells with significant gap formation, which was significantly improved after PerC. Western blot analysis demonstrated that expression of tight junction (TJ) protein occludin was significantly increased, but other elements of TJ proteins, claudin-5 and ZO-1, in the BBB endothelial cells were not altered at 48 h after PerC, compared to MCAO group. The expression of matrix metalloproteinase (MMP-9), which was involved in TJ protein degradation, was decreased after PerC. Interestingly, phosphorylated extracellular signal-regulated kinase 1/2 (pERK1/2), an upstream of MMP-9 signaling, was significantly reduced in the PerC group. Our data suggest that PerC inhibits MMP-9-mediated occludin degradation, which could lead to decreased BBB disruption and brain edema after ischemic stroke.

Entities:  

Keywords:  blood-brain barrier; ischemic stroke; matrix metalloproteinases; remote ischemic perconditioning; tight junction

Year:  2015        PMID: 26618042      PMCID: PMC4657812          DOI: 10.14336/AD.2015.0812

Source DB:  PubMed          Journal:  Aging Dis        ISSN: 2152-5250            Impact factor:   6.745


  43 in total

Review 1.  Remote ischemic perconditioning--a simple, low-risk method to decrease ischemic reperfusion injury: models, protocols and mechanistic background. A review.

Authors:  Attila Szijártó; Zoltán Czigány; Zsolt Turóczi; László Harsányi
Journal:  J Surg Res       Date:  2012-07-28       Impact factor: 2.192

2.  Remote ischemic post-conditioning reduced brain damage in experimental ischemia/reperfusion injury.

Authors:  Changhong Ren; Mingqing Gao; David Dornbos; Yuchuan Ding; Xianwei Zeng; Yumin Luo; Xunming Ji
Journal:  Neurol Res       Date:  2011-06       Impact factor: 2.448

3.  Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke.

Authors:  J Montaner; J Alvarez-Sabín; C A Molina; A Anglés; S Abilleira; J Arenillas; J Monasterio
Journal:  Stroke       Date:  2001-12-01       Impact factor: 7.914

4.  Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model.

Authors:  L Belayev; O F Alonso; R Busto; W Zhao; M D Ginsberg
Journal:  Stroke       Date:  1996-09       Impact factor: 7.914

5.  VE-cadherin and claudin-5: it takes two to tango.

Authors:  Julie Gavard; J Silvio Gutkind
Journal:  Nat Cell Biol       Date:  2008-08       Impact factor: 28.824

6.  Ischemic postconditioning diminishes matrix metalloproteinase 9 expression and attenuates loss of the extracellular matrix proteins in rats following middle cerebral artery occlusion and reperfusion.

Authors:  Xiang-Rong Liu; Mei Luo; Feng Yan; Chen-Cheng Zhang; Si-Jie Li; Hai-Ping Zhao; Xun-Ming Ji; Yu-Min Luo
Journal:  CNS Neurosci Ther       Date:  2012-08-23       Impact factor: 5.243

7.  Protective effects of remote ischemic conditioning against ischemia/reperfusion-induced retinal injury in rats.

Authors:  Xuxiang Zhang; Yunneng Jizhang; Xiaoying Xu; Timothy D Kwiecien; Ning Li; Ying Zhang; Xunming Ji; Changhong Ren; Yuchuan Ding
Journal:  Vis Neurosci       Date:  2014-04-15       Impact factor: 3.241

8.  Phase I clinical trial for the feasibility and safety of remote ischemic conditioning for aneurysmal subarachnoid hemorrhage.

Authors:  Nestor R Gonzalez; Mark Connolly; Joshua R Dusick; Harshal Bhakta; Paul Vespa
Journal:  Neurosurgery       Date:  2014-11       Impact factor: 4.654

9.  The chronic protective effects of limb remote preconditioning and the underlying mechanisms involved in inflammatory factors in rat stroke.

Authors:  Dingtai Wei; Chuancheng Ren; Xiaoyuan Chen; Heng Zhao
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

Review 10.  Mmp-9 inhibition: a therapeutic strategy in ischemic stroke.

Authors:  Mayank Chaturvedi; Leszek Kaczmarek
Journal:  Mol Neurobiol       Date:  2013-09-12       Impact factor: 5.590

View more
  28 in total

1.  Combined preconditioning with hypoxia and GYKI-52466 protects rats from cerebral ischemic injury by HIF-1α/eNOS pathway.

Authors:  Yuchan Yang; Fang Lu; Lihua Zhuang; Shuohui Yang; Yingnan Kong; Wenli Tan; Zhigang Gong; Songhua Zhan
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  The role of the lectin-like oxLDL receptor (LOX-1) in traffic-generated air pollution exposure-mediated alteration of the brain microvasculature in Apolipoprotein (Apo) E knockout mice.

Authors:  JoAnn Lucero; Usa Suwannasual; Lindsay M Herbert; Jacob D McDonald; Amie K Lund
Journal:  Inhal Toxicol       Date:  2017-08-17       Impact factor: 2.724

3.  Prevention of the collapse of pial collaterals by remote ischemic perconditioning during acute ischemic stroke.

Authors:  Junqiang Ma; Yonglie Ma; Bin Dong; Mischa V Bandet; Ashfaq Shuaib; Ian R Winship
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

4.  Pentoxifylline Alleviates Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats: Possibly via Inhibiting TLR 4/NF-κB Signaling Pathway.

Authors:  Da-Yong Xia; Hua-Sheng Zhang; Ling-Yun Wu; Xiang-Sheng Zhang; Meng-Liang Zhou; Chun-Hua Hang
Journal:  Neurochem Res       Date:  2016-12-08       Impact factor: 3.996

5.  LCZ696 Possesses a Protective Effect Against Homocysteine (Hcy)-Induced Impairment of Blood-Brain Barrier (BBB) Integrity by Increasing Occludin, Mediated by the Inhibition of Egr-1.

Authors:  Wenfeng Li; Wenjin Yuan; Dandan Zhang; Shuchun Cai; Jun Luo; Kanghua Zeng
Journal:  Neurotox Res       Date:  2021-09-20       Impact factor: 3.911

6.  Microcystin-leucine-arginine causes blood-testis barrier disruption and degradation of occludin mediated by matrix metalloproteinase-8.

Authors:  Yabing Chen; Jing Wang; Chun Pan; Dongmei Li; Xiaodong Han
Journal:  Cell Mol Life Sci       Date:  2017-10-25       Impact factor: 9.261

7.  Anfibatide Preserves Blood-Brain Barrier Integrity by Inhibiting TLR4/RhoA/ROCK Pathway After Cerebral Ischemia/Reperfusion Injury in Rat.

Authors:  Peng Gong; Rui Li; Hui-Yu Jia; Zheng Ma; Xiao-Yi Li; Xiang-Rong Dai; Sheng-Yong Luo
Journal:  J Mol Neurosci       Date:  2019-09-03       Impact factor: 3.444

8.  Preclinical Pharmacokinetics, Tissue Distribution, and Plasma Protein Binding of Sodium (±)-5-Bromo-2-(α-Hydroxypentyl) Benzoate (BZP), an Innovative Potent Anti-ischemic Stroke Agent.

Authors:  Xin Tian; Hong-Meng Li; Jing-Yao Wei; Bing-Jie Liu; Yu-Hai Zhang; Gao-Ju Wang; Jun-Biao Chang; Hai-Ling Qiao
Journal:  Front Pharmacol       Date:  2016-08-18       Impact factor: 5.810

9.  Antiretroviral Treatment with Efavirenz Disrupts the Blood-Brain Barrier Integrity and Increases Stroke Severity.

Authors:  Luc Bertrand; Levi Dygert; Michal Toborek
Journal:  Sci Rep       Date:  2016-12-23       Impact factor: 4.379

10.  Galanin Protects from Caspase-8/12-initiated Neuronal Apoptosis in the Ischemic Mouse Brain via GalR1.

Authors:  Yun Li; Zhu Mei; Shuiqiao Liu; Tong Wang; Hui Li; Xiao-Xiao Li; Song Han; Yutao Yang; Junfa Li; Zhi-Qing David Xu
Journal:  Aging Dis       Date:  2017-02-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.